These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5410698)

  • 21. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Venditti JM
    Cancer Treat Rev; 1980 Dec; 7(4):167-76. PubMed ID: 7214373
    [No Abstract]   [Full Text] [Related]  

  • 22. National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis.
    Cherian MG; Huang PC; Klaassen CD; Liu YP; Longfellow DG; Waalkes MP
    Cancer Res; 1993 Feb; 53(4):922-5. PubMed ID: 8428370
    [No Abstract]   [Full Text] [Related]  

  • 23. Translational research in the National Cancer Institute's cooperative groups.
    Symmans WF
    Clin Adv Hematol Oncol; 2014 Nov; 12(11):785-7. PubMed ID: 25674720
    [No Abstract]   [Full Text] [Related]  

  • 24. Scientists recall progress and promise of translational research.
    Marwick C
    J Natl Cancer Inst; 2001 Jan; 93(1):13-5. PubMed ID: 11136835
    [No Abstract]   [Full Text] [Related]  

  • 25. The National Cancer Institute: cancer drug discovery and development program.
    Grever MR; Schepartz SA; Chabner BA
    Semin Oncol; 1992 Dec; 19(6):622-38. PubMed ID: 1462164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C.R.O.S. conference on combined modalities chemotherapy/radiotherapy. Hilton Head Island, South Carolina, November 15--18, 1978.
    Carter SK
    Cancer Chemother Pharmacol; 1979; 2(2):139-42. PubMed ID: 43777
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of investigational radiation modifiers.
    Colevas AD; Brown JM; Hahn S; Mitchell J; Camphausen K; Coleman CN;
    J Natl Cancer Inst; 2003 May; 95(9):646-51. PubMed ID: 12734315
    [No Abstract]   [Full Text] [Related]  

  • 28. Commentary. Management of the National Cancer Institute's drug research program through application of the linear array concept.
    Rothenberg L; Terselic RA
    Cancer Chemother Rep; 1970 Oct; 54(5):303-10. PubMed ID: 5514618
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemoprevention research at the U.S. National Cancer Institute.
    Greenwald P
    Mil Med; 1994 Jul; 159(7):505-12. PubMed ID: 7816223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Nov; 44(11):721-3. PubMed ID: 7226778
    [No Abstract]   [Full Text] [Related]  

  • 31. Reports from the Workshop on the Use of Steroids as Carriers of Cytotoxic Agents in Breast Cancer: Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute.
    Cancer Treat Rep; 1978 Aug; 62(8):1239. PubMed ID: 28830
    [No Abstract]   [Full Text] [Related]  

  • 32. The limited precision of phase I trials.
    Christian MC; Korn EL
    J Natl Cancer Inst; 1994 Nov; 86(22):1662-3. PubMed ID: 7966387
    [No Abstract]   [Full Text] [Related]  

  • 33. National cancer institute perspectives.
    Wong RS; Brechbiel MW
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S96-9. PubMed ID: 16979449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The discovery and development of new antileukemic drugs.
    Grever M; Malspeis L
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):233-54. PubMed ID: 8449860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accessing investigational anticancer agents outside of clinical trials.
    Montello MJ; Greenblatt JJ; Fallavollita A; Shoemaker D
    Am J Health Syst Pharm; 1998 Apr; 55(7):651-2, 660. PubMed ID: 9558419
    [No Abstract]   [Full Text] [Related]  

  • 36. History of the National Cancer Institute and the plant screening program.
    Schepartz SA
    Cancer Treat Rep; 1976 Aug; 60(8):975-7. PubMed ID: 791487
    [No Abstract]   [Full Text] [Related]  

  • 37. The NCI Developmental Therapeutics Program.
    Collins JM
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):271-3. PubMed ID: 16728938
    [No Abstract]   [Full Text] [Related]  

  • 38. The Cancer Chemotherapy Programs, 1965.
    Cancer Chemother Rep; 1966 Oct; 50(7):397-460. PubMed ID: 5921754
    [No Abstract]   [Full Text] [Related]  

  • 39. Information services of the International Cancer Research Data Bank (ICRDB) program in cancer chemotheraphy and pharmacology.
    Schneider JH
    Adv Pharmacol Chemother; 1980; 17():25-35. PubMed ID: 7446305
    [No Abstract]   [Full Text] [Related]  

  • 40. The National Cancer Institute radiation development program.
    Pistenma DA
    Cancer Treat Rev; 1980 Dec; 7(4):225-34. PubMed ID: 7214374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.